US Drug Recall Register

FDA Drug Recalls

2,277 recalls · Class II, newest first

Class II · Moderate risk Ongoing

Medline

Reason Subpotent Drug

Medline Industries, LP NDC 55329-811-30 D-0035-2026
Class II · Moderate risk Ongoing

Doxycycline Hyclate Tablets

Reason Failed dissolution specifications: Stability testing found that the lot did not meet dissolution specifications.

Acella Pharmaceuticals, LLC NDC 42192-501-05 D-0014-2026
Class II · Moderate risk Ongoing

Afco

Reason cGMP deviations: The recall was initiated because required receipt testing of incoming alcohol components used to manufacture the listed hand sanitizers was not performed, so methanol risk could not be excluded.

Acuity Specialty Products, Inc. D-0005-2026
Class II · Moderate risk Ongoing

Wyandotte

Reason cGMP deviations: The recall was initiated because required receipt testing of incoming alcohol components used to manufacture the listed hand sanitizers was not performed, so methanol risk could not be excluded.

Acuity Specialty Products, Inc. D-0004-2026
Class II · Moderate risk Ongoing

Succinylcholine Chloride Injection

Reason Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.

Dr. Reddy's Laboratories, Inc. D-0008-2026
Class II · Moderate risk Ongoing

Aloe Up Sport Performance Sunscreen Lotion SPF 30

Reason cGMP deviations: the firm released and distributed product which failed total aerobic microbial count testing.

SV Labs Prescott Corporation D-0022-2026
Class II · Moderate risk Ongoing

Entecavir Tablets

Reason Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity

Zydus Pharmaceuticals (USA) Inc NDC 68382-921-06 D-0002-2026
Class II · Moderate risk Ongoing

Entecavir Tablets

Reason Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity

Zydus Pharmaceuticals (USA) Inc NDC 68382-920-06 D-0001-2026
Class II · Moderate risk Ongoing

Fentanyl citrate

Reason CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results.

Park Avenue Compounding NDC 83863-4272-1 D-0178-2026
Class II · Moderate risk Ongoing

Sting Relief Swabs

Reason Product Mix-up

Acme United Corporation D-0122-2026
Class II · Moderate risk Ongoing

Atorvastatin Calcium Tablets USP

Reason Failed Dissolution Specifications

Ascend Laboratories, LLC NDC 67877-514-90 D-0020-2026
Class II · Moderate risk Ongoing

Atorvastatin Calcium Tablets USP

Reason Failed Dissolution Specifications

Ascend Laboratories, LLC NDC 67877-512-90 D-0019-2026
Class II · Moderate risk Ongoing

Atorvastatin Calcium Tablets USP

Reason Failed Dissolution Specifications

Ascend Laboratories, LLC NDC 67877-513-90 D-0018-2026
Class II · Moderate risk Ongoing

Atorvastatin Calcium Tablets USP

Reason Failed Dissolution Specifications

Ascend Laboratories, LLC NDC 67877-511-90 D-0017-2026
Class II · Moderate risk Ongoing

Azelaic Acid Gel

Reason CGMP Deviations: Market complaints received for gritty texture (grainy)

Glenmark Pharmaceuticals Inc., USA NDC 68462-626-52 D-0662-2025
Class II · Moderate risk Ongoing

Phenylephrine HCI

Reason CGMP Deviations

Park Avenue Compounding NDC 83863-0104-1 D-0200-2026
Class II · Moderate risk Ongoing

Levothyroxine Sodium Tablets

Reason Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.

Accord Healthcare, INC. NDC 16729-450-15 D-0006-2026
Class II · Moderate risk Ongoing

Carbamazepine Extended-Release Tablets

Reason Failed Dissolution Specifications.

Amerisource Health Services LLC NDC 60687-594-21 D-0675-2025
Class II · Moderate risk Ongoing

edunn clarity

Reason Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.

Private Label Skin Care Inc. D-0668-2025
Class II · Moderate risk Ongoing

Micronized BPO Gel Cleanser 10%

Reason Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.

Private Label Skin Care Inc. D-0667-2025
Class II · Moderate risk Ongoing

mel rx Skin

Reason Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.

Private Label Skin Care Inc. D-0666-2025
Class II · Moderate risk Ongoing

Torrey Pines Dermatology & Laser Center Benzaderm BPO Cleanser 10%

Reason Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.

Private Label Skin Care Inc. D-0665-2025
Class II · Moderate risk Ongoing

Skin MD by Dr Monika Kiripolsky

Reason Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.

Private Label Skin Care Inc. D-0664-2025
Class II · Moderate risk Ongoing

Artisan of Skin

Reason Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.

Private Label Skin Care Inc. D-0663-2025